High intensity training and cardiovascular toxicity in cancer
DOI:
https://doi.org/10.24054/cbs.v1i2.2635Keywords:
Cardiotoxicity, high intensity exercise, physiotherapyAbstract
Introduction: Survival in oncology patients has an increasing percentage, as well as the prevalence of cardiovascular diseases because of antineoplastic treatment; timely diagnosis and intervention in an interdisciplinary manner, being essential to reduce and/or prevent cardiovascular conditions. Objective: To determine the efficacy of high intensity training on cardiovascular toxicity in cancer. Materials and methods: A chronological and retrospective descriptive systematic review of articles analyzed between 2018 and 2022 was conducted, according to the criteria of the PRISMA declaration and evaluating the methodology under the criteria of the PEDro scale. Information was collected on the population, group characteristics, intervention, effects, and results. Results: Nine clinical trials were analyzed, with a total of 724 oncological participants under chemotherapy treatment, and it was found that HIIT training improved ejection fraction (39.6±7.3 vs 46.5±2.4; p= 0.005), maximum heart rate (154.0± 13.0 vs 168.5±8.0; p= 0.005), systolic blood pressure (133.5±6.2 vs 122.0±1.6; p= 0.005), diastolic blood pressure (86.5±10.3 vs 81.0± 2.4; p= 0.005). In addition, it increases VO2 levels, strength and reduces fatigue associated with cancer, among other variables. Conclusion: HIIT not only leads to significant improvements in functional capacity and quality of life, but also emerges as a potentially promising strategy to prevent cardiotoxicity associated with antineoplastic therapies.
Downloads
References
Adams S. DeLorey D. Davenport M. et al. (2017). Effects of high-intensity aerobic interval training on cardiovascular disease risk in testicular cancer survivors: A phase 2 randomized controlled trial. Cancer. 123(20), 4057–4065. DOI: 10.1002/cncr.30859. DOI: https://doi.org/10.1002/cncr.30859
Ansund J. Mijwel S. Bolam K. et al. (2021). High intensity exercise during breast cancer chemotherapy - effects on long-term myocardial damage and physical capacity - data from the OptiTrain RCT. Cardio-Oncology. 7 (7). DOI: 10.1186/s40959-021-00091-1 DOI: https://doi.org/10.1186/s40959-021-00091-1
Bell R, Baldi J, Jones L. (2021). Additional cardiovascular fitness when progressing from moderate- to high-intensity exercise training in previously trained breast cancer survivors. Support Care Cancer. 29, 6645–6650. DOI: 10.1007/s00520-021-06259-w DOI: https://doi.org/10.1007/s00520-021-06259-w
Chung R. Ghosh A., Banerjee A. (2018). Cardiotoxicidad: medicina de precisión con definiciones imprecisas. Corazón abierto. 5 (2). DOI: 10.1136/openhrt-2018-000774 DOI: https://doi.org/10.1136/openhrt-2018-000774
Force T, Kolaja KL. (2011). Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes. Nat Rev Drug Discov. 10 (2): 111-126. DOI:10.1038/nrd3252 DOI: https://doi.org/10.1038/nrd3252
Hameau R. Gabrielli L. Garrido M. et al. (2018). Cardiotoxicidad inducida por tratamientos oncológicos. Fundamentos para la implementación de equipos de Cardio-Oncología. Revista médica de Chile. 146(1): 68-77. DOI: 10.4067/s0034-98872018000100068 DOI: https://doi.org/10.4067/s0034-98872018000100068
Kesting S, Weeber P, Schönfelder M. et al. (2022). Bout of High-Intensity Interval Training (HIIT) in Children and Adolescents during Acute Cancer Treatment—A Pilot Feasibility Study. Cancers. 14, 1468. DOI: 10.3390/cancers14061468 DOI: https://doi.org/10.3390/cancers14061468
Koutsoukis A, Ntalianis A, Repasos E. et al. (2018). Cardio-oncología: un enfoque en la cardiotoxicidad. Cardiología europea. 13 (1): 64–69. DOI: 10.15420/ecr.2017:17:2 DOI: https://doi.org/10.15420/ecr.2017:17:2
Lavie CJ. Arena R. Swift DL. et al. (2015). Exercise and the cardiovascular system: clinical science and cardiovascular outcomes. Circ Res. 117 (2): 207-219. doi:10.1161/CIRCRESAHA.117.305205 DOI: https://doi.org/10.1161/CIRCRESAHA.117.305205
Lee K, Kang I, Mack W, et al. (2019). Effects of high-intensity interval training on vascular endothelial function and vascular wall thickness in breast cancer patients receiving anthracycline-based chemotherapy: a randomized pilot study. Breast Cancer Res Treat. 177: 477–485. DOI: 10.1007/s10549-019-05332-7
Lee K. Norris M. Wang E. et al. (2021). Effect of high-intensity interval training on patient-reported outcomes and physical function in women with breast cancer receiving anthracycline-based chemotherapy. Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer. 29 (11). DOI: 10.1007/s00520-021-06294-7 DOI: https://doi.org/10.1007/s00520-021-06294-7
Lee K, Dieli C. (2020). Effect of High Intensity Interval Training on High-sensitivity C-reactive Protein in Breast Cancer Patients Undergoing Anthracycline-based Chemotherapy. Circulation. 17, Vol. 142, Suppl. 3. DOI 10.1161/circ.142.suppl_3.12538 DOI: https://doi.org/10.1161/circ.142.suppl_3.12538
Lee K. Kang I. Mack W. et al. (2019). Feasibility of high intensity interval training in patients with breast Cancer undergoing anthracycline chemotherapy: a randomized pilot trial. BMC cancer. 19 (1), 653. DOI: 10.1186/s12885-019-5887-7 DOI: https://doi.org/10.1186/s12885-019-5887-7
Lee K. Kang I. Mack W. (2019). Effects of high-intensity interval training on vascular endothelial function and vascular wall thickness in breast cancer patients receiving anthracycline-based chemotherapy: a randomized pilot study. Breast cancer research and treatment. 177 (2), 477–485. DOI: 10.1007/s10549-019-05332-7 DOI: https://doi.org/10.1007/s10549-019-05332-7
Maher C, Sherrington C, Herbert R, et al. (2003). Reliability of the PEDro scale for rating quality of randomized controlled trials. Phys Ther. 83(8):713-21. DOI: https://doi.org/10.1093/ptj/83.8.713
Meneses J. González E. Correa J. et al. (2015). Effectiveness of physical exercise on fatigue in cancer patients during active treatment: a systematic review and meta-analysis. Scielo. 31 (4), 667- 681.
Mijwel S. Backman M. Bolam K. et al. (2018). Highly favorable physiological responses to concurrent resistance and high-intensity interval training during chemotherapy: the OptiTrain breast cancer trial. Breast Cancer Res Treat. 169: 93–103. DOI: 10.1007/s10549-018-4663-8 DOI: https://doi.org/10.1007/s10549-018-4663-8
Mijwel S, Backman M, Bolam K, et al. (2018). Adding high-intensity interval training to conventional training modalities: optimizing health-related outcomes during chemotherapy for breast cancer: the OptiTrain randomized controlled trial. Breast Cancer Res Treat. 168: 79–93. DOI: 10.1007/s10549-017-4571-3 DOI: https://doi.org/10.1007/s10549-017-4571-3
Morales Y. Rodolfo A. Sierra L. et al. (2018). Cardiotoxicidad inducida por quimioterapia. CorSalud. 10(1): 68-77.
Nakano J. Hashizume K. Fukushima T. et al. (2018). Effects of Aerobic and Resistance Exercises on Physical Symptoms in Cancer Patients: A Meta-analysis. Integrative cancer therapies. 17 (4), 1048–1058. DOI: https://doi.org/10.1177/1534735418807555
Nandini N. Gongora E. (2016). Heart failure in chemotherapy-related cardiomyopathy: Can exercise make a difference? BBA Clinical. (6), 69-75. DOI:10.1016/j.bbacli.2016.06.001. DOI: https://doi.org/10.1016/j.bbacli.2016.06.001
Organización Mundial de la Salud. Cáncer. 2022. Recuperado de: https://www.who.int/es/news-room/fact-sheets/detail/cancer
Plana JC, Galderisi M, Barac A, et al. (2014). Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging.15(10):1063-1093. doi:10.1093/ehjci/jeu192. DOI: https://doi.org/10.1093/ehjci/jeu192
Pereira J, De Souza G. Lara J, et al. (2022) Efecto cardioprotector del ejercicio MICT y HIIT en la cardiotoxicidad de pacientes con cáncer de mama o próstata. Ensayo clínico aleatorizado. Cardiovasc Metab Sci. 33(s2): s106-s137.
Pereira-Rodríguez, J.E., Peñaranda-Florez, D.G., Pereira-Rodríguez, R., et al. (2020). Fatiga asociada al cáncer de mama luego de un programa de entrenamiento. Acta Médica Costarricense, 62 (1), 18–25. DOI: https://doi.org/10.51481/amc.v62i1.1056 DOI: https://doi.org/10.51481/amc.v62i1.1056
Santos C, Pimenta C, Nobre M. (2007). The PICO strategy for the research question construction and evidence search. Revista Latinoamericana de Enfermagem.15(3), 508–511. 3. DOI: https://doi.org/10.1590/S0104-11692007000300023
Sara M. Kate A. Jacob G. et al. (2020). Efectos del ejercicio en la finalización de la quimioterapia y las tasas de hospitalización: el ensayo de cáncer de mama OptiTrain, The Oncologist. 25 (1): 23 – 32. DOI: 10.1634/theoncologist.2019-0262 DOI: https://doi.org/10.1634/theoncologist.2019-0262
Smith LA. Cornelius VR. Plummer CJ. et al. (2010). Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials. BMC Cancer. 10: 337. DOI:10.1186/1471-2407-10-337 DOI: https://doi.org/10.1186/1471-2407-10-337
Toohey K, Pumpa K, McKune A. et al. (2020). El impacto del ejercicio de entrenamiento por intervalos de alta intensidad en sobrevivientes de cáncer de mama: un estudio piloto para explorar el estado físico, la regulación cardíaca y los biomarcadores de los sistemas de estrés. BMC Cáncer. 20, 787. DOI: 10.1186/s12885-020-07295-1 DOI: https://doi.org/10.1186/s12885-020-07295-1
Toohey K, Pumpa K, Arnolda L. et al. (2017). A pilot study examining the effects of low-volume high-intensity interval training and continuous low to moderate intensity training on quality of life, functional capacity, and cardiovascular risk factors in cancer survivors. PeerJ., 4. DOI: 10.7717/peerj.2613 DOI: https://doi.org/10.7717/peerj.2613
Urrútia G, Bonfill X. (2010). Declaración PRISMA: una propuesta para mejorar la publicación de revisiones sistemáticas y metaanálisis. Medicina Clínica.135(11), 507–511. DOI: https://doi.org/10.1016/j.medcli.2010.01.015
Von K, Vogt M, Oberhoffer R. et al. (2016). Triatleta competitivo juvenil después de la terapia con antraciclinas cardiotóxicas para la leucemia mieloide aguda. Cardio-Oncología 2, 8. DOI: 10.1186/s40959-016-0016-0. DOI: https://doi.org/10.1186/s40959-016-0016-0
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Revista Ciencias Básicas en Salud
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
